Cresco Labs Analyst Ratings
Cresco Labs Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/18/2022 | 313.22% | Cantor Fitzgerald | $19 → $15 | Maintains | Overweight |
03/24/2022 | 147.93% | Piper Sandler | $14 → $9 | Maintains | Overweight |
11/15/2021 | 423.42% | Cantor Fitzgerald | $12 → $19 | Maintains | Overweight |
11/03/2021 | 230.58% | Cantor Fitzgerald | $12.65 → $12 | Maintains | Overweight |
08/05/2021 | 271.9% | Cantor Fitzgerald | $21.5 → $13.5 | Maintains | Overweight |
07/07/2021 | 891.74% | Jefferies | → $36 | Initiates Coverage On | → Buy |
01/20/2021 | 478.51% | Cantor Fitzgerald | $18 → $21 | Maintains | Overweight |
11/19/2020 | 395.87% | Cantor Fitzgerald | $16 → $18 | Maintains | Overweight |
10/30/2020 | 340.77% | Cantor Fitzgerald | $15 → $16 | Maintains | Overweight |
08/21/2020 | 313.22% | Cantor Fitzgerald | $11 → $15 | Maintains | Overweight |
06/12/2020 | 15.7% | Needham | → $4.2 | Initiates Coverage On | → Hold |
05/29/2020 | 203.03% | Cantor Fitzgerald | $9.5 → $11 | Maintains | Overweight |
05/27/2020 | 161.71% | Cantor Fitzgerald | $8 → $9.5 | Maintains | Overweight |
04/28/2020 | 120.39% | Cantor Fitzgerald | $10 → $8 | Maintains | Overweight |
03/30/2020 | 175.48% | Cantor Fitzgerald | $12 → $10 | Maintains | Overweight |
02/14/2020 | 230.58% | Cantor Fitzgerald | → $12 | Initiates Coverage On | → Overweight |
09/13/2019 | 285.67% | Cowen & Co. | → $14 | Initiates Coverage On | → Outperform |
08/13/2019 | 203.03% | Piper Sandler | → $11 | Initiates Coverage On | → Overweight |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
08/18/2022 | 313.22% | 坎託·菲茨傑拉德 | 19 美元 → 15 美元 | 維持 | 超重 |
2022 年 3 月 24 日 | 147.93% | 派珀·桑德勒 | 14 美元 → 9 美元 | 維持 | 超重 |
11/15/2021 | 423.42% | 坎託·菲茨傑拉德 | 12 美元 → 19 美元 | 維持 | 超重 |
11/03/2021 | 230.58% | 坎託·菲茨傑拉德 | 12.65 美元 → 12 美元 | 維持 | 超重 |
08/05/2021 | 271.9% | 坎託·菲茨傑拉德 | 21.5 美元 → 13.5 美元 | 維持 | 超重 |
2021 年 7 月 7 日 | 891.74% | 傑富瑞 | → 36 美元 | 啓動覆蓋範圍開啓 | → 購買 |
2021 年 1 月 20 日 | 478.51% | 坎託·菲茨傑拉德 | 18 美元 → 21 美元 | 維持 | 超重 |
11/19/2020 | 395.87% | 坎託·菲茨傑拉德 | 16 美元 → 18 美元 | 維持 | 超重 |
10/30/2020 | 340.77% | 坎託·菲茨傑拉德 | 15 美元 → 16 美元 | 維持 | 超重 |
08/21/2020 | 313.22% | 坎託·菲茨傑拉德 | 11 美元 → 15 美元 | 維持 | 超重 |
06/12/2020 | 15.7% | 尼德姆 | → 4.2 美元 | 啓動覆蓋範圍開啓 | → 按住 |
2020 年 5 月 29 日 | 203.03% | 坎託·菲茨傑拉德 | 9.5 美元 → 11 美元 | 維持 | 超重 |
05/27/2020 | 161.71% | 坎託·菲茨傑拉德 | 8 美元 → 9.5 美元 | 維持 | 超重 |
04/28/2020 | 120.39% | 坎託·菲茨傑拉德 | 10 美元 → 8 美元 | 維持 | 超重 |
2020 年 3 月 30 日 | 175.48% | 坎託·菲茨傑拉德 | 12 美元 → 10 美元 | 維持 | 超重 |
02/14/2020 | 230.58% | 坎託·菲茨傑拉德 | → 12 美元 | 啓動覆蓋範圍開啓 | → 超重 |
09/13/2019 | 285.67% | Cowen & Co. | → 14 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
08/13/2019 | 203.03% | 派珀·桑德勒 | → 11 美元 | 啓動覆蓋範圍開啓 | → 超重 |
Cresco Labs Questions & Answers
Cresco Labs 問題與解答
The latest price target for Cresco Labs (OTCQX: CRLBF) was reported by Cantor Fitzgerald on August 18, 2022. The analyst firm set a price target for $15.00 expecting CRLBF to rise to within 12 months (a possible 313.22% upside). 4 analyst firms have reported ratings in the last year.
坎託·菲茨傑拉德於2022年8月18日公佈了Cresco Labs(場外交易代碼:CRLBF)的最新目標股價。該分析公司將目標股價設定爲15.00美元,預計CRLBF將在12個月內上漲至15.00美元(可能上漲313.22%)。去年有4家分析公司公佈了評級。
The latest analyst rating for Cresco Labs (OTCQX: CRLBF) was provided by Cantor Fitzgerald, and Cresco Labs maintained their overweight rating.
Cresco Labs(場外交易代碼:CRLBF)的最新分析師評級由坎託·菲茨傑拉德提供,Cresco Labs維持其增持評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cresco Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cresco Labs was filed on August 18, 2022 so you should expect the next rating to be made available sometime around August 18, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Cresco Labs的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月進行一次評級,因此每家公司每年應獲得4個評級。Cresco Labs的最後一次評級是在2022年8月18日提交的,因此您應該預計下一個評級將在2023年8月18日左右公佈。
While ratings are subjective and will change, the latest Cresco Labs (CRLBF) rating was a maintained with a price target of $19.00 to $15.00. The current price Cresco Labs (CRLBF) is trading at is $3.63, which is out of the analyst's predicted range.
儘管評級是主觀的,並將發生變化,但Cresco Labs(CRLBF)的最新評級維持不變,目標股價爲19.00美元至15.00美元。Cresco Labs(CRLBF)目前的交易價格爲3.63美元,超出了分析師的預測區間。